1. Home
  2. TLSA vs EVTL Comparison

TLSA vs EVTL Comparison

Compare TLSA & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$1.15

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

N/A

Current Price

$0.61

Market Cap

235.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TLSA
EVTL
Founded
2013
2016
Country
United Kingdom
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
145.1M
235.6M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
TLSA
EVTL
Price
$1.15
$0.61
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
★ $7.97
$7.13
AVG Volume (30 Days)
545.0K
★ 5.3M
Earning Date
05-01-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.52
52 Week High
$2.33
$7.35

Technical Indicators

Market Signals
Indicator
TLSA
EVTL
Relative Strength Index (RSI) 59.09 39.26
Support Level $0.90 $0.52
Resistance Level $1.20 $1.42
Average True Range (ATR) 0.09 0.07
MACD 0.02 0.02
Stochastic Oscillator 94.69 27.62

Price Performance

Historical Comparison
TLSA
EVTL

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

Share on Social Networks: